Related references
Note: Only part of the references are listed.Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus
Val M. Runge
INVESTIGATIVE RADIOLOGY (2016)
Diagnostic criteria for hepatocellular carcinoma ≤3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging
Sang Hyun Choi et al.
JOURNAL OF HEPATOLOGY (2016)
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Jung Hee Kim et al.
MEDICINE (2016)
Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial
Michael P. Achiam et al.
PEERJ (2016)
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands
Suzanne van Meer et al.
JOURNAL OF HEPATOLOGY (2015)
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging-A Systematic Review and Meta-Analysis
Yoon Jin Lee et al.
RADIOLOGY (2015)
Efficiency of Non-Contrast-Enhanced Liver Imaging Sequences Added to Initial Rectal MRI in Rectal Cancer Patients
Gene-hyuk Kwon et al.
PLOS ONE (2015)
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI
Kyung Ah Kim et al.
ABDOMINAL IMAGING (2014)
Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma
Yi Kyung Kim et al.
MAGNETIC RESONANCE IMAGING (2014)
Small Hepatocellular Carcinomas: Improved Sensitivity by Combining Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging Patterns
Min Jung Park et al.
RADIOLOGY (2012)
Can the Patient With Cirrhosis Be Imaged for Hepatocellular Carcinoma Without Gadolinium?: Comparison of Combined T2-Weighted, T2*-Weighted, and Diffusion-Weighted MRI With Gadolinium-Enhanced MRI Using Liver Explantation Standard
Andrew D. Hardie et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2011)
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases
Gilles Piana et al.
JOURNAL OF HEPATOLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Diffusion-weighted MR Imaging of the Liver
Bachir Taouli et al.
RADIOLOGY (2010)
MRI Safety Update 2008: Part I, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Frank G. Shellock et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
Salleh Ibrahim et al.
AMERICAN JOURNAL OF SURGERY (2007)
Nephrogenic systemic fibrosis: Risk factors and incidence estimation
Elizabeth A. Sadowski et al.
RADIOLOGY (2007)
Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines
Henrik S. Thomsen et al.
EUROPEAN RADIOLOGY (2006)
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes
SA Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Resection and liver transplantation for hepatocellular carcinoma
JM Llovet et al.
SEMINARS IN LIVER DISEASE (2005)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma
YJ Chen et al.
GASTROENTEROLOGY (2000)
Share Paper
